2-Methoxystypandrone displays an immunomodulatory effect in a cellular model, it blocks inflammatory responses by impairing NF-κB signaling to limit the inflammation and oxidative stress for preservation of BBB integrity. 2-Methoxystypandrone concomitant

2-Hydroxycinnamaldehyde is a natural product.

Prodigiosin hydrochloride, a red pigment, is a bioactive secondary metabolite produced by bacteria. It exhibits potent proapoptotic activity and functions as an inhibitor of the Wnt/β-catenin pathway. Additionally, this compound possesses antibacterial, antifungal, antiprotozoal, antimalarial, immunosuppressive, and anticancer properties.

YW1128 is an inhibitor of Wnt/β-catenin signaling with an IC50 value of 4.1 nM in a reporter assay.1 It decreases protein levels of β-catenin in the presence of the GSK3β inhibitor lithium chloride and increases protein levels of Axin1 in HEK293 cells. YW1128 decreases lipid accumulation and the expression of gluconeogenic and lipogenic genes in Huh7 cells. It decreases the hepatic expression of Wnt target genes, improves glucose tolerance, and prevents body weight increases and hepatic lipid accumulation in mice fed a high-fat diet, but not mice fed normal chow, when administered at a dose of 40 mg/kg every other day for 11 weeks.References1. Obianom, O.N., Ai, Y., Li, Y., et al. Triazole-based inhibitors of the Wnt/β-catenin signaling pathway improve glucose and lipid metabolism in diet-induced obese mice. J. Med. Chem. 62(2), 727-741 (2019). YW1128 is an inhibitor of Wnt/β-catenin signaling with an IC50 value of 4.1 nM in a reporter assay.1 It decreases protein levels of β-catenin i

Gypenoside LI是一种具有抗癌活性的天然产物，能够产生ROS，下调procaspase-8和MMP-2/9，抑制Wnt/β-catenin，引起细胞周期阻滞和凋亡。

Pterostilbene-isothiocyanate是一种 Wnt/β-catenin 信号通路抑制剂。它通过阻断 β-catenin 与 TCF-4 的结合抑制肿瘤增殖和迁移，用于骨肉瘤研究。

ME-143为第二代特异性NADH氧化酶抑制剂，针对结直肠癌细胞中WNT/β-catenin通路展现抑制作用。该化合物在体外及体内显示出广泛的抗癌活性。

4,10-Aromadendranediol exhibits neurite outgrowth-inducing activity in neurons via activation of the ERK signaling pathway, which may be beneficial to the treatment of brain diseases.

β-Cateninmodulator-4 (compound IIa-92) 为恶唑与噻唑类化合物，兼具高效性与选择性，作为β-Catenin调节剂。